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In Brief
The extent to which arteriolar smooth
muscle cell or capillary pericyte
contractility regulates regional cerebral
blood flow is debated. Hill et al. use
optogenetic, whisker stimulation,
spreading depolarization, and transient
cerebral ischemia to demonstrate that
capillary pericytes are not contractile
in vivo and that arteriolar smooth muscle
cells mediate physiological and
pathological vasomotion.
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The precise regulation of cerebral blood flow is crit-
ical for normal brain function, and its disruption un-
derlies many neuropathologies. The extent to which
smooth muscle-covered arterioles or pericyte-
covered capillaries control vasomotion during neuro-
vascular coupling remains controversial. We found
that capillary pericytes in mice and humans do not
express smooth muscle actin and are morphologi-
cally and functionally distinct from adjacent preca-
pillary smooth muscle cells (SMCs). Using optical
imaging we investigated blood flow regulation at
various sites on the vascular tree in livingmice. Opto-
genetic, whisker stimulation, or cortical spreading
depolarization caused microvascular diameter or
flow changes in SMC but not pericyte-covered mi-
crovessels. During early stages of brain ischemia,
transient SMC but not pericyte constrictions were
a major cause of hypoperfusion leading to throm-
bosis and distal microvascular occlusions. Thus,
capillary pericytes are not contractile, and regulation
of cerebral blood flow in physiological and patholog-
ical conditions is mediated by arteriolar SMCs.
INTRODUCTION
Cerebral function consumes a large amount of energy; however,
the precise locations and extent of neural activity within regions
of the brain are constantly fluctuating. Consequently, the brain
has evolved a specialized system to ensure coupling between
energy demand and supply through precise spatial and temporal
modulation of cerebral blood flow (CBF) (Hamel, 2006; Iadecola,
2004; Raichle and Mintun, 2006; Roy and Sherrington, 1890).
While the mechanisms controlling neurovascular coupling
are not well understood, previous work demonstrates the
involvement of complex interactions between neurons, glia,
and vascular cells (Haydon and Carmignoto, 2006; Iadecola
and Nedergaard, 2007; Kety and Schmidt, 1948; Roy and Sher-rington, 1890). Neural activation induces transient local micro-
vascular dilations, leading to increased blood flow and tissue
oxygenation, a phenomenon that forms the basis for functional
magnetic resonance imaging (fMRI) (Logothetis et al., 2001;
Ogawa et al., 1990). The modulation of vessel diameter, vascular
resistance, and blood flow is controlled by cells within themicro-
vascular wall (mural cells), which have contractile properties. A
precise understanding of the function of these cells in vivo is
important not only for investigating the source of the signals
obtained with fMRI blood-oxygen-level-dependent (BOLD) tech-
niques (Attwell and Iadecola, 2002; Logothetis and Wandell,
2004; Raichle and Mintun, 2006) but also for elucidating the
pathophysiology of many diseases involving the brain microvas-
culature (Iadecola and Nedergaard, 2007; Puro, 2007; Winkler
et al., 2014).
Mural cells on the cerebral vascular tree include arteriolar
and venular smooth muscle cells (SMCs) and capillary pericytes
(Rouget, 1874). These cells are thought to play important roles in
microvascular development, angiogenesis (Armulik et al., 2010;
Daneman et al., 2010), and maintenance of the blood brain bar-
rier (Bell et al., 2010), and are implicated in a variety of neuro-
pathological conditions (Bell et al., 2010; Hall et al., 2014; Sagare
et al., 2013; Yemisci et al., 2009). It is well known that microvas-
cular smooth muscle regulates vessel diameter and blood flow
(Brian et al., 1998; Devor et al., 2007; Ferna´ndez-Klett et al.,
2010; Kornfield and Newman, 2014; Vanzetta et al., 2005).
However, within brain microregions, the precise location where
neural activity-induced vasomotion is modulated is less clear.
Specifically, which segments of the vascular tree, especially
at the transition between arterioles and terminal capillaries, are
the primary sites of CBF regulation remains a topic of debate
(Armulik et al., 2011; Hamilton et al., 2010; Iadecola and Neder-
gaard, 2007; Itoh and Suzuki, 2012; Krueger and Bechmann,
2010; Winkler et al., 2011).
Recent studies have suggested capillaries to bemajor sites for
active CBF regulation (Chaigneau et al., 2003; Hall et al., 2014;
Peppiatt et al., 2006). In fact, it was estimated that up to 84%
of blood flowmodulation may take place at the terminal capillary
level, where pericytes are the predominant mural cell, suggest-
ing that these cells have prominent contractile properties (Hall
et al., 2014). However, separate studies in the cortex and retina
suggest that while pericyte contractility does occur, the directNeuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 95
role of capillaries in flow control may not be very significant
(Ferna´ndez-Klett et al., 2010; Kornfield and Newman, 2014). In
addition to physiological control of microvascular flow, in cere-
bral ischemia, constriction of capillary pericytes that persists
after their death has been proposed to prevent tissue reperfu-
sion, leading to the ‘‘no-reflow’’ phenomenon (Hall et al., 2014;
O’Farrell and Attwell, 2014; Yemisci et al., 2009). However, the
difficulty in distinguishing the various mural cell types in vivo,
especially at the transition between arterioles and capillaries,
and the variability in experimental methodologies have brought
the concept of physiological and pathological capillary pericyte
contractility into question (Vates et al., 2010). Resolution of these
discrepancies is of great importance not only because of its im-
plications for modeling physiological microregional blood flow
and brain oxygenation, but also for understanding the role of
the microvasculature and mural cells in neuropathological
conditions.
We utilized a combination of genetically encoded microvas-
cular mural cell labeling, high-resolution imaging of vasomotor
activity, functional calcium imaging, and optogenetic cell activa-
tion to precisely characterize the structural and functional prop-
erties of cerebral vascular mural cells in vivo. We demonstrate
that capillaries are incapable of active vasomotor responses to
a variety of stimuli such as direct pericyte optogenetic stimula-
tion, physiological neural activation, and spreading depolariza-
tion. Pericytes in brain capillaries completely lack expression
of smooth muscle actin (SMA), consistent with our finding that
only microvessels enveloped by mural cells with a circumferen-
tial band-like morphology, typical of smooth muscle, display
active vasomotor responses. Furthermore, we find that the
diameter and branch order of precapillaries with circumferential
smooth muscle is frequently indistinguishable from that of peri-
cyte-covered capillaries. Thus, ambiguous distinction between
these cell types could partly explain contradicting reports about
capillary pericyte contractility. Finally, we demonstrate that dur-
ing brain ischemia, SMC but not pericyte constriction leads to
vessel occlusion due to secondary thrombus formation within
distal microvessels. Our study provides functional and structural
in vivo evidence defining the cellular components of the micro-
vascular contractile apparatus, with important implications for
future studies of the normal and pathological regulation of CBF.
RESULTS
Morphologically Distinct Mural Cells along the Brain
Microvascular Tree
In order to perform a comprehensive study of the vasomotor
properties of mural cells, we first set out to determine their pre-
cise distributions and morphological features at various loca-
tions within the vascular tree in the mouse cerebral cortex. A
detailed morphological analysis was necessary in order to accu-
rately define the various mural cells that could potentially control
CBF, as inconsistencies in cell definition and identification likely
contribute to contradicting reports in the literature. We first
imaged mice that expressed membrane-bound GFP (mGFP)
specifically in cells with constitutive or inducible Cre recombi-
nase driven by the NG2 promoter (NG2cre:mT/mG and
NG2creER:mT/mG). NG2cre mice have Cre expression specif-96 Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc.ically in SMCs, pericytes, NG2 cells, and oligodendrocytes,
each of which can be clearly distinguished by their morphology
and close association with vessels, as described previously
(Hill et al., 2014; Zhu et al., 2008). In constitutive NG2cre mice,
Cre recombination efficiency was sufficient to observe near-
complete mGFP labeling of NG2-expressing mural cells, while
single isolated cells could be visualized in inducible NG2creER
mice after a single injection of tamoxifen. This approach revealed
cells with distinct morphologies at each level of the vascular tree
(Figure 1 and see Figure S1 available online).
Cells with classical smooth muscle morphology, forming nar-
row circumferential bands that surround the entire vessel, were
found on pial and penetrating arterioles with diameters ranging
from 15 to 40 mm (Figures 1A and S1). On more distal vessels,
3–15 mm in diameter, we also observed similar band-like cells
with variable lengths, all of which enveloped the entire vessel
circumference (Figures 1B–1G and S1). Based on their circum-
ferential band-like morphology, we classified these two mural
cell populations as arteriole and precapillary SMCs, respec-
tively. Within the subset of smaller microvessels, with diameters
ranging from 3 to 9 mm, we also observed morphologically
distinct cells with processes that extended longitudinally for hun-
dreds of microns along multiple capillary branchpoints (Figures
1B–1H and S1). In addition to their long processes, these cells
also had short and thin processes that projected orthogonally
across the vessel but rarely spanned its entire circumference
(Figure S1). We classified this type of cell as capillary pericytes,
due to their unique morphology and location. Immediately adja-
cent cells in postcapillary venules displayed a band-like circum-
ferential phenotype similar to arteriolar smooth muscle, but
spanned larger distances and had a highly fenestrated patch-
work-like appearance (Figures 1A, 1B, and 1G).
To further distinguish the various mural cell types, we crossed
NG2cre mice with the brainbow-like Cre dependent confetti
reporter (NG2cre:confetti). Consistent with mT/mG reporter
mice, we could precisely identify morphologically distinct single
cells (due to differential fluorescent protein labeling) with either
SMC or pericyte morphology, further delineating the single
cell territories and discrete morphologies of each cell type
(Figure S2).
Spontaneous Vasomotion and Mural Cell Calcium
Fluctuations in Awake Mice
We then set out to determine the contractile properties of vessels
at various levels of the vascular tree. We used in vivo two-photon
imaging to measure spontaneous single-vessel diameter
changes in the somatosensory cortex of awake head-fixed
NG2cre:ZEGmice injected with an intravascular dye to visualize
all vessels. In vivo time-lapse imaging in these mice revealed
that 10–50 mm diameter arterioles with a layer of cells with
SMC morphology spontaneously dilated and contracted at rela-
tively high frequencies, while venules rarely displayed significant
diameter changes. We focused our analysis on vessels smaller
than 10 mm in diameter, as this is where we observed the transi-
tion from precapillary SMCs to capillary pericytes (Figures 1
and 2A–2D). Consistent with the heterogeneous mural cell
morphology that we observed, these vessels displayed highly
variable spontaneous vasomotion that did not correlate well
Figure 1. Distinct Morphology of Mural Cells along the Cortical Vascular Tree
(A) In vivo image captured from the cortex of an NG2cre:mT/mG transgenic mouse showing mGFP (green)-expressing smooth muscle cells on arterioles and
venules with mTomato (red) expression in all membranes.
(B) In vivo images showing detailed morphology of mGFP labeled cells on pre- and postcapillary vessels (left), precapillary arterioles covered by single smooth
muscle cells (middle, arrowheads), and capillaries covered by a single pericyte (right, arrow); numbers indicate vessel diameter.
(C) In vivo two-photon image showing mGFP expression on a penetrating arteriole and several branches (branch order indicated) demonstrating the transition
from smooth muscle cell morphology (arrowheads) to capillary pericytes (arrows). Vessels are labeled via intravascular dye.
(D and E) Images showing transitions from mGFP-labeled smooth muscle cell morphology (arrowheads) to capillary pericytes (arrows).
(F) Image captured from the cortex of an NG2creER:mT/mG transgenic mouse showing isolated mGFP-labeled cells after a single injection of tamoxifen.
(G) Single-cell circumferential morphology of smoothmuscle cells on arterioles (top), precapillary arterioles (middle), and postcapillary venules (bottom); numbers
indicate vessel diameter.
(H) Single-cell morphology of capillary pericytes extending longitudinally over hundreds of microns (arrows).
See also Figures S1 and S2.with their respective diameters (Figure 2A–2D; Movie S1). To
accurately describe this contractile behavior, we quantified the
area under the curve of the percent changes in vessel diameter(Figures 2C, 2F, and 2G), a measure that accounts for amplitude,
frequency, and duration of diameter changes, and which we
termed vasomotion index (see Experimental Procedures). ThisNeuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 97
Figure 2. Awake Imaging of Spontaneous Vasomotion along the Cortical Vascular Tree
(A) In vivo images captured from the cortex of awake head-fixed NG2cre:ZEG transgenic mice showing GFP (green) labeled smooth muscle (arrowheads),
pericytes (white arrows), and NG2 cells (blue arrows), while vessels are labeled via intravascular dye (red).
(B) Line-scan time series showing spontaneous diameter changes of the vessels shown in (A).
(C) Diameter changes of four vessel segments with (magenta, green, orange) or without (blue) smooth muscle cells shown in (A) and (B).
(D) Smooth muscle cells on a precapillary arteriole (arrowheads).
(E) Line-scan time series showing spontaneous diameter changes of the vessels shown in (D).
(F) Diameter changes of the four vessel segments with (magenta and green) or without (orange and blue) smooth muscle cells shown in (D) and (E).
(G) The relationship between vessel diameter and a vasomotion index defined as the area under the curve for percent spontaneous changes in vessel diameter
with a ±5% cutoff threshold, n = 47 vessel segments from 4 mice.
See also Movie S1.quantification revealed that the heterogeneous spontaneous
diameter changes were clearly correlated to the type of mural
cell covering these vessels (Figure 2G) (vasomotion indices: pre-
capillary SMC-covered vessels 38.2 ± 6.3; capillary pericyte-
covered vessels 1.8 ± 0.5, p < 0.001 unpaired t test).
To further characterize and correlate a functional intracellular
signal in single mural cells with changes in vessel diameter, we
generated mice with a Cre-dependent genetically encoded cal-
cium indicator (GCaMP3) expressed specifically in NG2-positive
mural cells (and some neurons, see below) (NG2cre:GCaMP3).
Detailed analysis of changes in GCaMP3 fluorescence intensity
showed SMC calcium transients preceding, coinciding with, or
following vasomotion, with a significant anticorrelation between
increases in SMC calcium and vessel dilation (Figures 3A, 3B,
and 3F; Movie S1) (correlation, r =0.49 ± 0.21 SD, n = 24 vessel
segments from 3 mice, significant differences from 0 correlation
determined by a 99% confidence interval).While transient robust
changes in GCaMP3 fluorescence were also detected in peri-
cytes, no changes in vessel diameter were detected (Figures
3C and 3D; Movie S3), and thus there was no correlation be-
tween pericyte calcium fluctuations and changes in vessel diam-
eter (Figures 3E and 3F) (correlation, r = 0.02 ± 0.07 SD, n = 12
pericytes from 3 mice).98 Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc.These morphological and functional data suggested that the
presence or absence of the different mural cell types determined
whether active vasomotion occurred in individual microvessels.
To directly test this hypothesis, we next looked for the presence
of contractile proteins to correlate molecular and cellular identity
with in vivo function.
Expression of SmoothMuscle Actin in Arterioles but Not
Capillaries in Mice and Humans
To understand the reasons behind the heterogeneous contrac-
tility in smaller vessels, we performed in vivo imaging of double
transgenic mice expressing the fluorescent protein mCherry
driven by the SMA promoter and endothelial GFP driven by the
Tie2 promoter (SMA-mCherry:Tie2-GFP). In these mice, all ves-
sels were labeled with GFP, and arterioles were envelopedwith a
bright layer of SMA-mCherry-labeled mural cells (Figures 4A and
4B). Artery specificity of mCherry was determined by the direc-
tionality of the blood flow and confirmed by labeling with intrave-
nously injected Alexa Fluor 633 hydrazide (Figure S4), which
binds to the elastin layer in arterioles (Shen et al., 2012). In addi-
tion to detecting bright SMA-mCherry on large penetrating ar-
teries and arterioles, we often observed mCherry expression
on smaller vessels with diameters less than 10 mm (Figures
Figure 3. Correlation between Vasomotion and Calcium Transients in Mural Cells In Vivo
(A) In vivo image from the cortex of an NG2cre:GCaMP3 transgenic mouse showing a penetrating arteriole and the transition from SMC-covered (1 and 2) to
pericyte-covered (3) vessels. Time-lapse sequences show the change in vessel diameter (dotted line) and corresponding changes in GCaMP3 fluorescence
(arrowheads).
(B) Traces of spontaneous changes in vessel diameter (red) overlayed with corresponding changes in GCaMP3 calcium fluorescence (green) in SMC-covered
arterioles and pericyte-covered capillaries.
(C) Time-lapse sequence showing spontaneous GCaMP3 calcium changes in a single pericyte cell body (arrow) and processes.
(D) Traces of changes in vessel diameter (red) overlayed with changes in pericyte GCaMP3 calcium signals (green). Arrows indicate changes in pericyte calcium
with no changes in capillary diameter.
(E) Example images and line-scan time series at each level of the vascular tree. Changes in vessel diameter occurred only on SMC-covered vessels which
corresponded to decreases in SMC GCaMP3 calcium signals (arrowheads). In contrast, peaks in pericyte calcium (arrow) correlated with no change in capillary
diameter.
(F) Quantification of the correlation between GCaMP3 calcium signals and changes in vessel diameter in SMCs (red) r = 0.49 ± 0.21 SD, and pericytes (blue)
r = 0.02 ± 0.07 SD, n = 24 SMC-covered vessels and 12 pericyte-covered vessels from 3 mice; asterisk indicates significant differences from 0 correlation
determined by a 99% confidence interval.
See also Movie S2 and Movie S3.4C–4G). Quantification revealed that the last SMA-mCherry-ex-
pressing cells at the transition between arterioles and capillaries
were found at both branchpoints and in the middle of single ves-
sels with diameters ranging from 3.3 to 8.5 mm (Average of 5.4 ±
1.3 mm) and branch orders ranging from first to fourth (0 being a
penetrating arteriole) (n = 45 vascular tress from 4 mice) (Figures
4C–4J). Unexpectedly, at the location of these terminal SMA-
mCherry-expressing cells, we frequently observed that thevessel diameter was smaller compared to the downstream
capillary (Figure 4G), strongly suggesting that mural cells in cap-
illaries are not capable of providing a baseline contractile tone
like distal SMCs.
To verify that the observed lack of SMA expression in capil-
laries was not due to incomplete mosaic expression in our
SMA-mCherry transgenic mice, we confirmed our observations
with immunohistochemistry for SMA (Figure 4K) as well as in aNeuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 99
Figure 4. Smooth Muscle Actin Is Expressed by Arteriole but Not Capillary Mural Cells in Mouse and Human Neocortex
(A) In vivo image captured from the cortex of a smooth muscle actin (SMA)-mCherry:Tie2-GFP transgenic mouse showing GFP (green) labeling in all vessels and
bright mCherry (red) expression in arterioles and precapillary vessels.
(B) A single GFP-labeled arteriole enveloped by a layer of SMA-labeled mCherry.
(C) Branching of a precapillary vessel showing the termination of SMA-mCherry-expressing cells (arrowheads) with vessel diameter indicated adjacent to single
vessels.
(D) SMA-mCherry expression in surface and penetrating arterioles with vessels labeled via intravascular dye (cyan). Vessel branch orders indicated in yellow.
(E) High-magnification image of the vessel outlined in (D) showing the termination of the last SMA-mCherry-expressing cell (arrowheads) on a fourth branch order
vessel; numbers in lower panel indicate vessel diameter.
(F and G) SMA-mCherry expression on precapillary vessels at different vascular tree levels. The last SMA-mCherry-expressing cells (panels on the right indicate
zoomed regions of terminal SMA+ cells shown on the left) are indicated with cell bodies (arrows) and terminal processes (arrowheads); numbers indicate vessel
diameter.
(H) Correlation of vessel branch order with that of the distribution of vessel diameters where the last SMA-mCherry-expressing smooth muscle cell is located.
(I) The percentage breakdown for the branch order on which terminal SMA+ cells are located.
(J) Correlation of vessel diameter with the distance from a vessel branch point where the last SMA-mCherry-expressing smooth muscle cell is located.
(K) Immnohistochemical staining of NG2cre:ZEG mouse necortex with antibodies for SMA (red) and PDGFRb (white) showing that SMA locates only at SMCs
on arterioles and precapillary arterioles (yellow arrowheads), while PDGFRb is expressed by both arteriolar SMCs and capillary pericytes (yellow arrows). GFP-
labeled cells in the parenchyma (blue arrows) are oligodendrocyte lineage cells.
(L) Immunohistochemical staining of human neocortex with antibodies for collagen IV (white) to label blood vessels and SMA (red) showing the transition from
SMA-covered precapillary arterioles to SMA-lacking capillaries (arrowheads); numbers indicate vessel diameter.
See also Figure S3.
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separate transgenic line with mGFP expressed specifically in
SMA+ cells (SMAcreER:mT/mG) (Figure S3). SMA antibody
staining showed identical expression to SMA-mCherry mice
and was not found in pericytes (Figures 4K and S4). In addition
to NG2 and SMA, expression of the b receptor for platelet
derived growth factor (PDGFRb) is routinely used to identify peri-
cytes. Importantly however, we found expression of PDGFRb on
both SMA+ SMCs and SMA pericytes (Figures 4K and S4).
In addition to seeing SMA-mCherry-labeled cells on arteries
and precapillary arterioles, due to bright fluorescence in these
mice, we also observed weak mCherry expression on large
venules (>50 mm), but not on smaller postcapillary vessels (Fig-
ure S3), suggesting that large venules have some limited con-
tractile potential. Importantly, the SMA expression in arterioles
and its absence from terminal capillaries was not unique to
mice, as we also observed it in human neocortex (Figure 4J).
Quantification of postmortem human tissues stained with anti-
bodies against SMA revealed that 8.5% ± 0.3% of the total
length of human intraparenchymal cerebral vessels (n = 3 human
samples) was enveloped with SMA-expressing mural cells.
Similar to mice, the last SMA-expressing cells at the transition
between arterioles and capillaries were found at both branch-
points and in the middle of single vessels, ranging from 4.63 to
15.5 mm in diameter (average diameter 9.1 ± 0.4 mm, n = 41
vascular trees from three human samples).
These data provide strong evidence that, regardless of vessel
diameter or branch order, SMA is expressed in mural cells with
circumferential SMC morphology but is absent from pericytes.
This provides a likely explanation for the heterogeneity in spon-
taneous vasomotion that we observed at the precapillary versus
capillary levels (Figure 2).
Optogenetic-Induced Vasomotion Only Occurs in
Smooth Muscle-Covered Vessels
To directly assess the contractile properties of individual cells
at various levels of the vascular tree, we generated double
transgenic mice which express a light gated proton channel
(channelrhodopsin 2, ChR2) fused to yellow fluorescent protein
(YFP) specifically in NG2-expressing cells (NG2cre:ChR2-
YFP) and crossed them with SMA-mCherry mice to generate
NG2cre:ChR2-YFP:SMA-mCherry triple transgenic mice. These
mice express ChR2-YFP in cortical pericytes, SMCs, oligoden-
drocyte lineage cells, and a small number of cortical astrocytes
as well as mCherry in all SMCs (Figure 5A). The presence
of voltage-gated calcium channels in both SMCs and peri-
cytes (Figure S5) (Borysova et al., 2013; Sakagami et al., 1999),
assured that ChR2 stimulation would cause depolarization of
both cell types.
Using these mice, we implemented a confocal laser line-
scan technique to optimally activate ChR2 and cause targeted
mural cell stimulation while simultaneously imaging vessel diam-
eter (see Experimental Procedures). In arterioles larger than
10 mm in diameter, which were covered by SMA-expressing
SMCs, light activation caused significant vessel constrictions
(19.41 ± 1.90% change in diameter, n = 58 vessels from 8
mice) (Figures 5B–5E). Similarly, light activation on vessels less
than 10 mm in diameter but still covered by SMA-expressing pre-
capillary SMCs, resulted in significant vessel constrictions (Fig-ures 5B–5E) (11.79 ± 2.06% constriction, n = 18 vessels from
8mice). In contrast, vessels less than 10 mm in diameter covered
by pericytes but not SMA-expressing SMCs showed no
constriction after identical light activation of ChR2 (Figures
5B–5E) (0.08 ± 0.18% change in diameter, 39 vessels from 8
mice). To exclude possible artifacts by non-mural-cell ChR2
stimulation in constitutive NG2cre:ChR2-YFP mice, we used
low-dose tamoxifen induction in NG2creER:ChR2-YFP, where
we were able to label cells very sparsely to isolate individual
SMCs and pericytes, thus removing any concern about nearby
expressing cells. ChR2 stimulation of isolated cells demon-
strated the same results, with SMC constriction and lack of
pericyte contractility (Figure S5).
Given that small and potentially difficult to detect changes
in vessel diameter can induce substantial changes in blood
flow proportional to the fourth power of radius changes (as per
Poiseuille equation of fluid dynamics), we directly tested the
impact of targeted ChR2 activation on blood-flow velocity. In
order to avoid potential out of focal plane ChR2 activation by
the confocal laser, which could prevent accurate local flowmea-
surements due to proximal vessel constrictions, we used instead
targeted two-photon stimulation of ChR2 within small regions
of interest (ROIs) along single vessels. Consistent with the
observed constrictions, ChR2 activation on vessels covered by
SMCs significantly reduced blood flow velocity (Figures 5F–5I)
(44.62 ± 11.80% change, n = 10 vessels from 3 mice), while
ChR2 activation on vessels that were not covered by SMCs
did not significantly change blood flow (Figure 5H-I) (2.22 ±
3.16% change, n = 30 vessels from 3 mice). These data strongly
demonstrate that in the intact mouse neocortex, single-cell
depolarization of SMCs, but not pericytes, results in robust
modulation of vessel diameter and CBF.
Neural Activity-Induced Vasomotion Does Not Occur in
Pericyte-Covered Capillaries
To determine which vessels respond to an increase in neuronal
activity and thus regulate functional hyperemia, we imaged the
vascular response towhisker stimulation in the awakemouse so-
matosensory cortex. To correlate neuronal activity with vascular
changes, we again used the NG2cre:GCaMP3 transgenic mice.
Unexpectedly, we found that in these mice both mural cells and
neurons are brightly labeled (Figure 6A), likely due to ectopic
neuronal Cre expression (Nishiyama et al., 2014). The dual label-
ing with GCaMP3 in neurons and NG2-expressing cells was very
useful because it allowed us to identify and image vessels with
SMCs and pericytes (Figure 6B) while concurrently monitoring
neuronal activity (Figures 6C and 6D).
We performed in vivo time-lapse imaging of vessel diameter
and neuronal and mural cell calcium changes during and after
sensory stimulation in the awake mouse. Whisker stimulation
(30 s of 5 Hz, 100 ms air puffs) evoked robust neuronal calcium
transients and significant vessel dilations (10% change at
peak dilation) in somatosensory cortex vessels covered with
smooth muscle (Figures 6E–6G) (significance determined by a
99% confidence interval, vessel diameter range 6.2–21 mm,
branch order 0–3, n = 57 vessels from 4 mice). This immediate
active dilation was not observed in vessels that lacked a smooth
muscle layer (Figures 6E–6G) (vessel diameter range 3.3–8.1 mm,Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 101
Figure 5. Single-Cell Optogenetic Activation Causes Vessel Constriction and Decreases Blood Flow in Smooth Muscle but Not Pericyte-
Covered Microvessels
(A) In vivo images captured from the cortex of anNG2cre:ChR2-YFP:SMA-mCherrymouse showing SMA (red) expression on arterioles and precapillary arterioles
and Chr2-YFP expression (green) on all vessels and a subpopulation of astrocytes.
(B) Line-scan time series images showing changes in vessel diameter after line-scan activation of ChR2 at various levels of the vascular tree with andwithout SMA
(indicated by numbers with location identified with white lines [A]).
(C) Paired examples showing locations of ChR2 activation (white lines) on vessels with and without SMA, with corresponding line-scan time series images
demonstrating that only SMA-covered vessels show vessel constriction.
(D) The average vessel diameter change in response to ChR2 activation (at time 0) on vessels with smooth muscle (arterioles, red line; precapillary arterioles,
orange line) and without smooth muscle (capillaries, blue line). Traces show mean values ± SEM, n = 58 arterioles, 18 precapillary arterioles, and 39 capillaries
from 8 mice. Asterisk indicates significance determined by a 99% confidence interval.
(E) The distribution of vessels that showed contractility in response to ChR2 activation in relation to vessel diameter.
(F) Method for determination of changes in blood flow velocity using the distortion of the image of a red blood cell as it moves (dotted line) during laser scanning
(relative velocity field scanning).
(G) A decrease in vessel diameter and blood flow on a SMC-covered vessel after optogenetic activation.
(H) No change in blood flow velocity after optogenetic activation in a pericyte-covered vessel.
(I) Quantification of the average change in blood flow velocity during optogenetic activation in SMC+ precapillary arterioles (red line) and SMC capillaries (blue line).
Tracesshowmeanvalues±SEM,n=10precapillary arteriolesand30capillaries from3mice.Asterisk indicatessignificancedeterminedbya99%confidence interval.
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Figure 6. Smooth Muscle but Not Pericyte-Covered Microvessels Undergo Active Sensory-Evoked Vasodilatation in Awake Mice
(A and B) In vivo images captured from the somatosensory barrel cortex of awake head-fixed NG2cre:GCaMP3 transgenic mice showing GCaMP3 (green)
baseline fluorescence labeling of smoothmuscle (arrowheads) and neurons (blue arrows) but very little in capillary pericytes (white arrows). Vessels are labeled via
intravascular dye (red).
(C) A single neuronal calcium response (box) to a whisker puff detected by a fluorescence intensity increase of the GCaMP3 signal.
(D) Trace showing the percent change in neuronal GCaMP3 fluorescence to five repeated whisker puffs.
(E) Image showing examples of GCaMP3-positive and -negative vessels analyzed from time-lapse images during 30 s of whisker stimulation.
(F) Line-scan time series images showing the GCaMP3 neuronal response and whisker-evoked dilation (arrows) of the vessels shown in (E).
(G) Quantification of the neuronal and vascular responses to whisker stimulation (black bar) with the average neuronal GCaMP3 fluorescence signal (green), the
average change in diameter of precapillary vessels with a smooth muscle layer (SMC+, red), capillaries lacking a smooth muscle layer (SMC, blue), and
GCaMP3 fluorescence signal in pericytes (magenta) and SMCs (orange). Traces show mean values ± SEM, n = 57 SMC+ vessel segments, 83 SMC vessel
segments from 4 mice for neuronal response and vessel diameter, and n = 24 SMCs and 12 pericytes from 3 mice for GCaMP3 traces. Asterisk indicates
significance compared to baseline determined by a 99% confidence interval coded by color for corresponding cell type (SMC or pericyte) and signal (vessel
diameter or GCaMP3).branch order 1–4, n = 83 vessels from 4mice). While, there was a
slight (1%) delayed dilation in vessels lacking smooth muscle,
this occurred after peak dilation had occurred in vessels with
SMCs, an effect that is most likely a passive result of upstream
increases in blood flow (Figure 6G). Whisker stimulation also
induced a robust decrease in calcium-dependent GCaMP3 fluo-rescence in SMCs which correlated temporally with changes in
vessel diameter (Figure 6G) (significance determined by a 99%
confidence interval, n = 19 vessel segments from 3 mice). In
contrast, changes in calcium-dependent GCaMP3 fluorescence
in pericytes were not correlated with whisker stimulation (Fig-
ure 6G) (n = 27 vessel segments from 3 mice). These dataNeuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 103
Figure 7. Cortical Spreading Depolarization Induces Vasomotion of Smooth Muscle but Not Pericyte-Covered Microvessels
(A) In vivo image captured from the cortex of an SMA-mCherry (red) transgenic mouse with neurons and astrocytes labeled with the Oregon Green Bapta-1AM
(OGB-1AM) calcium indicator (green) and vessels labeled via intravascular dye (blue).
(B) Region depicted in (A) of the transition from precapillary SMA-covered vessel (arrows) to capillary pericyte-covered vessel (arrowheads); numbers indicate
baseline vessel diameters.
(C) Time sequence showing the OGB-1AM fluorescence intensity and vessels at baseline, during KCl-induced spreading depolarization, and during the recovery
period; numbers indicate vessel diameters.
(D) Line-scan time series images showing KCl-induced change in vessel diameter in an SMA+ vessel, but not in the downstream SMA– vessel.
(E) Quantification of the neuronal and vascular responses to spreading depolarization (gold bar) with the average neural OGB-1AM fluorescence signal (green),
the average change in diameter of precapillary vessels with a smooth muscle layer (SMA+, red), and capillaries lacking a smooth muscle layer (SMA, blue).
Traces showmean values ± SEM, n = 10 SMA+ vessels, and 10 SMA vessels from 3mice. Asterisk indicates significance compared to baseline determined by a
99% confidence interval.strongly suggest that in the awake mouse cortex, functional
hyperemia is mediated by calcium-dependent arteriolar SMC
contractility rather than direct capillary pericyte contractility.
Vasomotor Responses during Cortical Spreading
Depolarization
Cortical spreading depolarization (CSD) occurs under numerous
pathological situations and results in altered CBF (Leao, 1944;
Somjen, 2001). To determine the precise location within the
vascular tree of CSD-induced vasomotor responses, we loaded
neural cells with the calcium-sensitive dye Oregon Green Bapta
1AM (OGB) in SMA-mCherry transgenic mice that had been104 Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc.intravenously injected with a fluorescent dye to visualize the
vessel lumen (Figures 7A and 7B).
To induce CSD, we performed a single microinjection of 0.5 M
potassium chloride (KCl) 1–2 mm from the imaging site. As
predicted, these injections resulted in prolonged increases in
OGB fluorescence intensity in neurons and astrocytes consis-
tent with the time course of CSD (Somjen, 2001) (Figures 7C–
7E). We detected significant diameter changes during CSD
that occurred exclusively in vessels with a smooth muscle layer
(25% increase at peak dilation, 10% decrease at peak
constriction, significance determined by a 99%confidence inter-
val, n = 10 vessels from 3 mice), but not in capillaries with
pericytes that lack SMA (n = 10 vessels from 3 mice) (Figures
7C–7E). Therefore, consistent with the optogenetic and sen-
sory-evoked experiments above, modulation of blood flow dur-
ing CSD is mediated by smooth muscle-covered vessels and
not by capillary pericytes.
Transient MCA Occlusion Induces Focal SMC
Constriction and Reperfusion Deficits
Finally, we tested if cerebral ischemia could induce focal con-
strictions in microvessels that could prevent re-establishment
of blood flow. We implemented a transient (90 min) filament
occlusion of the middle cerebral artery (tMCAO) (see Experi-
mental Procedures), and we performed in vivo imaging of cere-
bral MCA branches before, during, after and 4 hr after reperfu-
sion (Figures 8A, S6A, and S6B). Consistent with our previous
experiments, we focused our analysis on the transition points
between the last SMC on precapillary arterioles and pericytes
on capillaries usingSMA-mCherry andNG2creER:mT/mG trans-
genic mice.
In order to sample a large region during and after tMCAO,
high-resolution tiled images covering the entire cranial window
were acquired (Figure S6). Confirmation of vessel occlusion dur-
ing tMCAO was determined by the presence of sluggish and tur-
bulent CBF and corresponding hypoxia-induced vessel dilation
evident in 20–30 mm diameter pial arterioles (Figure S6C). Preca-
pillary arteriolar-to-capillary transitions were analyzed in these
vessels by noting and measuring changes in vessel perfusion
and diameter. We observed multiple outcomes both during
and after the tMCAO, particularly at the last SMC. These terminal
SMCs often displayed focal constrictions that were transient
and observed only during MCAO or induced during MCAO and
maintained after reperfusion (Figures 8B–8E, S7, and S8A).
These focal SMC constrictions resulted in RBC perfusion block
to downstream capillaries which either maintained some plasma
flow (Figures 8E and S7; Movie S4, Movie S5, and Movie S6) or
displayed complete vessel occlusion (Figures 8B–8D and S7).
RBC perfusion block was observed in 48 out of 59 SMC-to-peri-
cyte transitions with 21 and 27 of those displaying reversible
or maintained focal SMC constrictions, respectively (Figures 8F
and 8G). Focal constrictions in capillaries were not observed
(Figures 8, S7, and S8) even at the location of pericyte cell
bodies, 4 and 24 hr after tMCAO, as previously reported (Hall
et al., 2014) (Figure S8). Measurement of vessel diameter in
RBC perfusion blocked SMC-to-pericyte transitions (see Fig-
ure 8F for measurement location diagram) revealed a significant
average decrease in vessel diameter at terminal SMCs, but not in
downstream same-branch or second-branch pericyte-covered
capillaries (Figure 8H) (n = 51 terminal SMC-covered precapillary
arterioles, 51 same-branch capillaries, and 27 second-branch
capillaries from 5 mice; significance determined by unpaired
two-tailed t test). Further characterization of all SMC to pericyte
transitions revealed a variety of perfusion and vessel change
outcomes during and after tMCAO (Figure 8I). These outcomes
were characterized as maintained RBC perfusion (Figure S10E),
only plasma perfusion (Figures 8 and S7), complete block with
thrombus (Figures 8 and S7), or vessel collapse/no intravascular
dye (Figures S7B and S7E) (defined as collapse or no i.v. dye
labeling spanning greater than 20 mm vessel length).Overall, these data suggest that during cerebral ischemia and
reperfusion, SMCs display focal constrictions that are transient
or prolonged. In combination with numerous other cellular pro-
cesses taking place during cerebral ischemia, these SMC con-
strictions appear to play a significant role as an early mechanism
that prevents tissue reflow, leading to potentially irreversible
microvascular occlusion.
DISCUSSION
We have precisely identified and functionally characterized
in vivo the contractile perivascular mural cells that control
neurovascular coupling and microregional CBF. Our results
demonstrate that CBF regulation takes place exclusively at
microvessels covered by SMCs that have a distinct circumfer-
ential morphology and express SMA (Figure S9). Several lines
of evidence demonstrate that capillary pericytes, which do not
express SMA and have a noncircumferential, longitudinal
morphology spanning long distances, do not have the capacity
for direct regulation of blood flow. First, in vivo spontaneous vas-
omotion in awake mice occurs in vessels covered by SMCs,
regardless of their diameter or branch order, but does not occur
in pericyte-covered vessels. Second, spontaneous calcium fluc-
tuations in SMCs correlate with vessel diameter changes, while
calcium fluctuations in pericytes do not induce changes in capil-
lary diameter. Third, single-cell in vivo optogenetic activation
of SMCs causes vessel constriction and flow reductions, while
identical activation of pericytes causes no capillary changes.
Fourth, sensory stimulation evokes a rapid and robust dilation
of SMC-covered vessels, but only a slow and nearly undetect-
able dilation of pericyte-covered capillaries which is likely to be
passive. Fifth, CSD induces active vasomotion in SMC-covered
vessels, but not in pericyte-covered capillaries. These multiple
lines of independent in vivo evidence demonstrate unambigu-
ously that capillary pericytes are not contractile and thus cannot
directly regulate CBF.
While the capillary network comprises the majority of the brain
vascular system, our data demonstrate that direct regulation of
blood flow occurs at the level of arteries, arterioles, and precapil-
laries. Our findings describing mural cell contractility and control
of CBF by arterioles greater than 10 mm in diameter are consis-
tent with a number of previous studies using tissue explant
preparations (Borysova et al., 2013; Kornfield and Newman,
2014) and in vivo brain vessel imaging (Devor et al., 2007;
Drew et al., 2011; Ferna´ndez-Klett et al., 2010; Iadecola et al.,
1997; Kornfield and Newman, 2014; Vanzetta et al., 2005).
Importantly, however, we have for the first time precisely estab-
lished a direct relationship between microvascular mural cell
molecular identity, single-cell morphology, and cellular function
at each level of the cerebral vascular tree in vivo. We unam-
biguously demonstrate that in vessels smaller than 10 mm in
diameter, at the transition between SMC and pericyte-covered
regions, there is great heterogeneity of contractile properties.
It is critical to note that vascular diameter and vessel branch
order are not reliable determinants of contractile capacity as mi-
crovessels smaller than 10 mm in diameter, with branch orders
ranging from first to fourth, are enveloped bymural cells with het-
erogeneous SMA expression and contractile capacity. PreviousNeuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 105
Figure 8. Transient MCA Occlusion Induces Focal SMC Constriction and Reperfusion Deficits
(A) Timeline for experimental transient (90 min) middle cerebral artery occlusion (tMCAO) with in vivo imaging. In vivo image from an SMA-mCherry transgenic
mouse (red) with intravascular dye (green) showing an example of a transition from SMC to pericyte-covered vessels depicted in (B).
(B and C) Repeated in vivo images captured before, during, after, and 4 hr after tMCAO showing prolonged (white arrowheads) or transient (blue arrow-
heads) SMC focal constrictions with maintained subsequent vessel blockage in downstream capillaries. Right-side panels in (B) are zoomed from boxed
region.
(D and E) Example vessel perfusion outcomes (blocked, plasma perfused, or RBC perfused) after SMC focal constrictions (arrowheads) due to tMCAO.
(F) Diagram showing the measurement locations on the vascular tree at the transition points between SMCs and pericytes for quantification in (G)–(I).
(G) Vessel perfusion outcomes 4 hr after tMCAO for all SMC to pericyte transitions; n = 59 transitions from 5 mice.
(legend continued on next page)
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studies have relied on vessel diameter, branch order, or both
to distinguish between arterioles and terminal capillaries. This
distinction cannot discriminate between SMA-expressing preca-
pillary SMCs and SMA-deficient capillary pericytes, and likely
contributes to seemingly contradictory conclusions from our
study and others (Ferna´ndez-Klett et al., 2010; Hall et al.,
2014). In addition to discrepancies from identifying terminal cap-
illaries by their location and size, it should also be noted that all
mural cells, including SMA-expressing SMCs, express the NG2
chondroitin sulfate proteoglycan and PDGFRb (Armulik et al.,
2011; Nakayama et al., 2013; Uemura et al., 2002). Therefore,
NG2 and PDGFRb expression cannot be used to unambiguously
distinguish pericytes from SMCs. Thus far, the only reliable
means to identify contractile vessels, particularly those with di-
ameters less than 10 mm, is by SMA expression and the distinc-
tion between circumferential band-like SMC versus longitudinal
pericyte morphologies.
The morphology of capillary pericytes provides some clues
about their functional role. In stark contrast with the robust
circumferential arrangement of SMCs, pericytes have thin
processes that extend longitudinally for distances of up to
300 mm, span multiple capillaries, and rarely wrap around ves-
sels (Figure S1). This arrangement does not appear to be struc-
turally suited for exerting radial forces capable of executing
vessel diameter changes. The observation that capillaries can
have even larger diameters than precapillary arterioles (Figures
2A and 4G) is highly suggestive of pericytes not even providing
a baseline contractile tone to the vessel. In addition to these ob-
servations, the logic for altering vessel diameter at the capillary
level as a mechanism for flow regulation is not clear. It is well
documented that RBCs need to undergo cell deformation in or-
der to move through 3–5 mm capillaries (Noguchi and Gompper,
2005; Pawlik et al., 1981; Skalak and Branemark, 1969). Thus, if
contractility existed in capillaries, it is likely that even small
changes in diameter would result in RBC perfusion block rather
than a graded change in flow, posing a significant risk of focal
microvascular thrombosis. We speculate that this phenomenon
explains why small precapillary vessels with terminal SMCs are
prone to irreversible distal microvascular occlusions after SMC
constriction during cerebral ischemia.
Instead of a contractile role for pericytes, we speculate that
the long, thin pericyte processes could provide a network for
sensing, transmitting, or coordinating information between the
neural and vascular compartments. Gap junction coupling be-
tween pericytes and endothelial and SMCs has been demon-
strated (Borysova et al., 2013; Cuevas et al., 1984; Oku et al.,
2001). Together with astrocytes (Simard et al., 2003), pericytes
may play a role in coordinating neurovascular coupling (Itoh
and Suzuki, 2012) through SMC contractility. Recent findings
showing sensory-evoked dilation in first-order vessels prior to
zero-order penetrating arterioles (Hall et al., 2014) could be ex-
plained if the signal to induce vasomotion is transmitted through(H) Average vessel diameter measurements ± SD at each location along the vas
noncollapsed vessels; n is indicated in table from 5 mice; p values obtained from
(I) Analysis of vessel perfusion during, after, and 4 hr after tMCAO at distinct loc
See also Figures S6–S8 and S10, and Movie S4, Movie S5, and Movie S6.local astrocytes and pericytes up the vascular tree, reaching
SMC-covered precapillary arterioles prior to upstream arterioles.
Intercellular communication between mural cells could also
partly explain some of the variability we observed in our correla-
tion experiments between SMC calcium and vasomotion. This
variability is likely due to a number of complex interactions be-
tween proximal and distal SMCs and how upstream and down-
stream changes in diameter can alter blood flow and resistance,
which could then independently alter vessel diameter in
the absence of active vasomotion at the location of our SMC cal-
cium measurements. However, even with these complex flow
dynamics and cellular interactions, a highly significant anticorre-
lationwas present between vasomotion and calcium fluctuations
in arteriolar SMCs but was absent from capillary pericytes.
In neuropathological states, such as ischemia, irreversible
pericyte constriction and death have been suggested to impair
capillary reflow (Hall et al., 2014; Yemisci et al., 2009). Instead,
we found that during early stages of ischemia and reperfusion
after MCA occlusion, focal constrictions occur exclusively in
vessels surrounded by SMCs (Figure S10). These constrictions
were either transient or maintained and appeared to lead
to downstream microvascular occlusion. We believe that the
contradictory observations of vascular contractility in ischemia
could stem from differences in experimental approaches (Vates
et al., 2010) and from the belief that pericytes express SMA
in vivo (Yemisci et al., 2009) and that SMCs are not located
on brain vessels other than zero-order penetrating arterioles
(Hall et al., 2014), which leads to misidentification of SMCs as
pericytes.
‘‘No reflow’’ after ischemia is likely a multifaceted, complex
phenomenon (Figure S10). The variable SMC contractile
behaviors and downstream flow outcomes in our data suggest
that there are numerous multicellular processes occurring
during both ischemia and reperfusion. SMC constrictions likely
contribute to the process by temporarily slowing or blocking
flow and thus initiating lumen thrombotic mechanisms and im-
pairing clot washout. However, additional intrinsic or extrinsic
mechanisms affecting the microvasculature, including capillary
plugging by leukocytes and platelets (del Zoppo et al., 1991),
luminal entrapment of thromboemboli by endothelial lamellipo-
dia (Grutzendler et al., 2014; Lam et al., 2010), and interstitial
swelling (Rezkalla and Kloner, 2002), are likely to significantly
contribute to microvascular occlusion, vessel collapse, and
impaired reperfusion.
Our anatomical data of the percentage of vessels covered by
SMA-expressing SMCs support a model in which CBF is directly
regulated by 8% (by length) of all intraparenchymal cerebral
microvessels. Given the distribution of penetrating and precapil-
lary arterioles (Blinder et al., 2013) and considering that only
those covered by SMA can regulate vessel diameter, we specu-
late that the resolution of CBF regulation is on the order of a
75–150 mm radius of tissue. Therefore, while the demand forcular tree before, during, after, and 4 hr after tMCAO specifically in blocked,
unpaired t test.
ations along the vascular tree; n is indicated from 5 mice.
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CBF changes may be detected at single capillaries, regulation of
functional hyperemia likely does not occur at this level, but
instead at SMC-covered precapillaries that feed relatively larger
brain volumes. In addition to advancing our understanding of
local tissue oxygenation, this observation has significant impli-
cations for techniques that use changes in CBF as a correlate
for neural activity. Given the spatial regulation of CBF we
observed, BOLD fMRI and optical imaging of intrinsic signals
(Grinvald et al., 1986) may have a fundamental hypothetical limit
in spatial resolution, independent of their technical limitations for
signal detection.
In addition to understanding normal CBF regulation, our find-
ings have important implications for neuropathology. SMC mal-
function on the already-small proportion of vessels covered by
SMCs could induce dramatic changes in neurovascular coupling
and CBF regulation for the entire brain. For example, cerebral
amyloid angiopathy, which occurs in Alzheimer’s disease due
to arteriolar accumulation of amyloid (Farkas and Luiten, 2001;
Iadecola, 2004), could cause SMCmalfunction on the small pro-
portion of proximal vessels, with major consequences on CBF
regulation for an entire volume that we estimate to have a radius
of 75–150 mm. Likewise, the functional outcome after occlusion
or loss of single microvessels during aging and a number of dis-
ease states (Armulik et al., 2011; Faraci, 2011; Harb et al., 2013;
Iadecola, 2004) likely depends on whether or not these vessels
are covered by SMCs or pericytes. Therefore, careful analysis
of distinct mural cells on single vessels directly affected by pa-
thology is necessary to fully understand cerebrovascular mal-
function in multiple disease states.
In summary, our study demonstrates that under normal and
pathological states, microvascular SMCs control CBF and neu-
rovascular coupling. These cells are morphologically, molecu-
larly, and functionally distinct from capillary pericytes, despite
the fact that they can be found on vessels traditionally defined
as capillaries, based on vessel diameter and/or branch order.
Thus, true cerebral capillary pericytes are not contractile in vivo
and do not independently regulate CBF but may have as-of-yet
unidentified noncontractile CBF regulatory functions.EXPERIMENTAL PROCEDURES
Animals
All animal experiments were approved by the Yale University Institutional An-
imal Care and Use Committee (IACUC). See also Supplemental Experimental
Procedures. The following transgenic mice were used: NG2cre (Zhu et al.,
2008) (Jackson Labs number 008533), NG2creER (Zhu et al., 2011) (Jackson
Labs number 008538), floxed ChR2-YFP (Madisen et al., 2012) (Jackson
Labs number 012569), SMA-mCherry (Armstrong et al., 2010); SMAcreER
(Wendling et al., 2009), mT/mG (Muzumdar et al., 2007) (Jackson Labs number
007676), Tie2-GFP (Motoike et al., 2000) (Jackson Labs number 003658), Z/EG
(Novak et al., 2000) (Jackson Labs number 003920), floxed GCaMP3 (Zariwala
et al., 2012) (Jackson Labs number 014538), andConfetti (Snippert et al., 2010)
(Jackson Labs number 013731). Male and female mice aged 4–16 weeks
were used and all experiments were in awake, alert, head-fixed mice or
mice anesthetized via intraperitoneal injection of 100 mg/kg ketamine and
10 mg/kg xylazine (k/x) by body weight as indicated.
Cranial Window Surgery and In Vivo Imaging
An acute cranial window preparation was used for all in vivo imaging experi-
ments as described previously (Hill and Grutzendler, 2014; Schain et al.,108 Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc.2014). For two-photon imaging, a mode-locked MaiTai laser (Spectra Physics)
was used on a two-photonmicroscope (Prairie Technologies) with a 203water
immersion objective (Zeiss 1.0 NA). In some cases a confocal (Leica SP5)
with a 203 water immersion objective (Leica 1.0 NA) was used for optimal flu-
orophore excitation and emission separation and for activation of channelrho-
dopsin (see below).
Channelrhodopsin Activation
Texas Red dextran (70,000 mw, Life Technologies catalog number D-1864) or
Cascade Blue dextran (10,000mw, Life Technologies catalog number D-1976)
were injected intravenously to label blood plasma and were used to determine
changes in vessel diameter and flow velocity. Analysis of single-cell
morphology (in addition to SMA-mCherry expression) as described in Figures
1–4 was carried out from high-resolution confocal or two-photon z stacks of
single mural cells expressing YFP fused to ChR2 that were acquired using light
wavelengths which were not optimal for stimulation of ChR2 but sufficient for
YFP excitation and detection (561 nm for confocal and 900 nm for two photon)
in order to avoid any chance of ChR2 stimulation due to imaging alone. To acti-
vate ChR2, a laser line-scan or ROI-based local activation was used. We used
a 473/488 nm confocal laser line-scan activation protocol for optimal excita-
tion of ChR2. In order to avoid potential artifacts from out-of-focus light-acti-
vating upstream vessels and causing nonspecific changes in flow, we used
two-photon laser stimulation (tuned to 800 nm) (Duan et al., 2014) to determine
the effect of single-cell activation on blood flow. While both were effective at
causing activation of ChR2, each method proved optimal for diameter and
flow measurements, respectively.
Whisker Stimulation
We used themouse whisker sensory system to test the effects of external sen-
sory input on diameter of vessels with and without smooth muscle expression
in the awakemouse somatosensory cortex (Figure 6). After cranial window sur-
geries, mice were allowed to recover from anesthesia before two-photon im-
aging and sensory stimulation. Dextran was injected intravenously to label
blood vessels and was used to determine changes in vessel diameter
described in data analysis. Whisker stimulation was done in awake head-fixed
mice using a small tube attached to a picospritzer (set to 30 psi) positioned
1–2 cm from the contralateral vibrissae. Stimulation consisted of 100 ms air
puffs at 5 Hz for 2 or 30 s as indicated.
Cortical Spreading Depolarization
To image vasomotor responses during CSD (Figure 7), 0.8 mM Oregon Green
488 BAPTA-1 AM (OGB) (Life Technologies catalog number O-6807) was pres-
sure injected through a pulled glass micropipette. To induce CSD, 0.5 mM KCl
was injected 1–2mm away from the imaging location. Time-lapse imaging was
performed before, during, and after the CSD induction in order to detect
the change in calcium in neurons and astrocytes with OGB and correlate
these changes with smooth muscle-labeled and nonlabeled vessel diameter
changes with intravascular dye.
Ischemia-Reperfusion by Middle Cerebral Artery Filament
Occlusion
Focal ischemia was induced by transient (90 min) middle cerebral artery occlu-
sion (tMCAO) using an intraluminal filament technique. The carotid artery was
exposed in theneck region, anda silicon rubber-coated6-0 nylonmonofilament
with 2 mm tip (230 mm diameter of the tip) was introduced into the common
carotid artery and advanced 9 mm along the internal carotid artery (ICA) until
occluding the origin of the MCA. After 90 min, the filament was withdrawn to
establish reperfusion.Prior toMCAO,acranialwindowwasprepared, and imag-
ing was performed using a two-photon or confocal microscope. Imaging was
performedbefore, during, immediately after, and4hrafter tMCAO.Vesselperfu-
sion at each stage was determined via detection of RBC flux using i.v. dyes.
Tissue Processing, Imaging Data, and Statistical Analyses
Mice were anesthetized and perfused with 2% or 4% paraformaldehyde, and
tissue was processed as outlined in Supplemental Experimental Procedures.
Detailed descriptions for data analyses can also be found in Supplemental
Experimental Procedures.
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org/10.1016/j.neuron.2015.06.001.
AUTHOR CONTRIBUTIONS
R.A.H., L.T., and P.Y. designed and performed experiments and analyzed
data. S.M. and S.G. performed experiments. R.A.H. and J.G. wrote the manu-
script. J.G. designed and supervised the experiments.
ACKNOWLEDGMENTS
We thank K. Hirschi (Yale University) for sharing SMA-mCherry transgenic
mice, D. Greif (Yale University) for sharing SMAcreERmice, A. Nishiyama (Uni-
versity of Connecticut) for sharing NG2cremice, Z.J. Zhou (Yale University) for
sharing ChR2-YFP and GCaMP3 mice, and M. Mesulam (Alzheimer Disease
Center at Northwestern University) for providing postmortem human tissue.
This work was supported by the following grants from the National Institutes
of Health: R01-HL106815 and R01-NS089734 to J.G., and F32-NS090820 to
R.A.H.
Received: January 14, 2015
Revised: April 24, 2015
Accepted: May 22, 2015
Published: June 25, 2015
REFERENCES
Armstrong, J.J., Larina, I.V., Dickinson, M.E., Zimmer, W.E., and Hirschi, K.K.
(2010). Characterization of bacterial artificial chromosome transgenic mice ex-
pressing mCherry fluorescent protein substituted for the murine smooth mus-
cle alpha-actin gene. Genesis 48, 457–463.
Armulik, A., Genove´, G., Ma¨e, M., Nisancioglu, M.H., Wallgard, E., Niaudet, C.,
He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010). Pericytes regulate
the blood-brain barrier. Nature 468, 557–561.
Armulik, A., Genove´, G., and Betsholtz, C. (2011). Pericytes: developmental,
physiological, and pathological perspectives, problems, and promises. Dev.
Cell 21, 193–215.
Attwell, D., and Iadecola, C. (2002). The neural basis of functional brain imag-
ing signals. Trends Neurosci. 25, 621–625.
Bell, R.D., Winkler, E.A., Sagare, A.P., Singh, I., LaRue, B., Deane, R., and
Zlokovic, B.V. (2010). Pericytes control key neurovascular functions and
neuronal phenotype in the adult brain and during brain aging. Neuron 68,
409–427.
Blinder, P., Tsai, P.S., Kaufhold, J.P., Knutsen, P.M., Suhl, H., and Kleinfeld, D.
(2013). The cortical angiome: an interconnected vascular network with nonco-
lumnar patterns of blood flow. Nat. Neurosci. 16, 889–897.
Borysova, L., Wray, S., Eisner, D.A., and Burdyga, T. (2013). How calcium
signals in myocytes and pericytes are integrated across in situ microvascular
networks and control microvascular tone. Cell Calcium 54, 163–174.
Brian, J.E., Faraci, F.M., and Feuerstein, G. (1998). Tumor necrosis factor-
induced dilatation of cerebral arterioles editorial comment. Stroke 29,
509–515.
Chaigneau, E., Oheim, M., Audinat, E., and Charpak, S. (2003). Two-photon
imaging of capillary blood flow in olfactory bulb glomeruli. Proc. Natl. Acad.
Sci. USA 100, 13081–13086.
Cuevas, P., Gutierrez-Diaz, J.A., Reimers, D., Dujovny, M., Diaz, F.G., and
Ausman, J.I. (1984). Pericyte endothelial gap junctions in human cerebral cap-
illaries. Anat. Embryol. (Berl.) 170, 155–159.
Daneman, R., Zhou, L., Kebede, A.A., and Barres, B.A. (2010). Pericytes are
required for blood-brain barrier integrity during embryogenesis. Nature 468,
562–566.del Zoppo, G.J., Schmid-Scho¨nbein, G.W., Mori, E., Copeland, B.R., and
Chang, C.M. (1991). Polymorphonuclear leukocytes occlude capillaries
following middle cerebral artery occlusion and reperfusion in baboons.
Stroke 22, 1276–1283.
Devor, A., Tian, P., Nishimura, N., Teng, I.C., Hillman, E.M.C., Narayanan, S.N.,
Ulbert, I., Boas, D.A., Kleinfeld, D., and Dale, A.M. (2007). Suppressed
neuronal activity and concurrent arteriolar vasoconstriction may explain nega-
tive blood oxygenation level-dependent signal. J. Neurosci. 27, 4452–4459.
Drew, P.J., Shih, A.Y., and Kleinfeld, D. (2011). Fluctuating and sensory-
induced vasodynamics in rodent cortex extend arteriole capacity. Proc. Natl.
Acad. Sci. USA 108, 8473–8478.
Duan, X., Krishnaswamy, A., De la Huerta, I., and Sanes, J.R. (2014). Type II
cadherins guide assembly of a direction-selective retinal circuit. Cell 158,
793–807.
Faraci, F.M. (2011). Protecting against vascular disease in brain. Am. J.
Physiol. Heart Circ. Physiol. 300, H1566–H1582.
Farkas, E., and Luiten, P.G. (2001). Cerebral microvascular pathology in aging
and Alzheimer’s disease. Prog. Neurobiol. 64, 575–611.
Ferna´ndez-Klett, F., Offenhauser, N., Dirnagl, U., Priller, J., and Lindauer, U.
(2010). Pericytes in capillaries are contractile in vivo, but arterioles mediate
functional hyperemia in the mouse brain. Proc. Natl. Acad. Sci. USA 107,
22290–22295.
Grinvald, A., Lieke, E., Frostig, R.D., Gilbert, C.D., and Wiesel, T.N. (1986).
Functional architecture of cortex revealed by optical imaging of intrinsic
signals. Nature 324, 361–364.
Grutzendler, J., Murikinati, S., Hiner, B., Ji, L., Lam, C.K., Yoo, T., Gupta, S.,
Hafler, B.P., Adelman, R.A., Yuan, P., and Rodriguez, G. (2014). Angiophagy
prevents early embolus washout but recanalizes microvessels through
embolus extravasation. Sci. Transl. Med. 6, 226ra31.
Hall, C.N., Reynell, C., Gesslein, B., Hamilton, N.B., Mishra, A., Sutherland,
B.A., O’Farrell, F.M., Buchan, A.M., Lauritzen, M., and Attwell, D. (2014).
Capillary pericytes regulate cerebral blood flow in health and disease.
Nature 508, 55–60.
Hamel, E. (2006). Perivascular nerves and the regulation of cerebrovascular
tone. J. Appl. Physiol. 100, 1059–1064.
Hamilton, N.B., Attwell, D., and Hall, C.N. (2010). Pericyte-mediated regulation
of capillary diameter: a component of neurovascular coupling in health and
disease. Front. Neuroenergetics 2, 1–14.
Harb, R., Whiteus, C., Freitas, C., and Grutzendler, J. (2013). In vivo imaging
of cerebral microvascular plasticity from birth to death. J. Cereb. Blood Flow
Metab. 33, 146–156.
Haydon, P.G., and Carmignoto, G. (2006). Astrocyte control of synaptic trans-
mission and neurovascular coupling. Physiol. Rev. 86, 1009–1031.
Hill, R.A., and Grutzendler, J. (2014). In vivo imaging of oligodendrocytes with
sulforhodamine 101. Nat. Methods 11, 1081–1082.
Hill, R.A., Patel, K.D., Goncalves, C.M., Grutzendler, J., and Nishiyama, A.
(2014). Modulation of oligodendrocyte generation during a critical temporal
window after NG2 cell division. Nat. Neurosci. 17, 1518–1527.
Iadecola, C. (2004). Neurovascular regulation in the normal brain and in
Alzheimer’s disease. Nat. Rev. Neurosci. 5, 347–360.
Iadecola, C., and Nedergaard, M. (2007). Glial regulation of the cerebral micro-
vasculature. Nat. Neurosci. 10, 1369–1376.
Iadecola, C., Yang, G., Ebner, T.J., and Chen, G. (1997). Local and propagated
vascular responses evoked by focal synaptic activity in cerebellar cortex.
J. Neurophysiol. 78, 651–659.
Itoh, Y., and Suzuki, N. (2012). Control of brain capillary blood flow. J. Cereb.
Blood Flow Metab. 32, 1167–1176.
Kety, S.S., and Schmidt, C.F. (1948). The effects of altered arterial tensions
of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen
consumption of normal young men. J. Clin. Invest. 27, 484–492.
Kornfield, T.E., and Newman, E.A. (2014). Regulation of blood flow in the retinal
trilaminar vascular network. J. Neurosci. 34, 11504–11513.Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc. 109
Krueger, M., and Bechmann, I. (2010). CNS pericytes: concepts, misconcep-
tions, and a way out. Glia 58, 1–10.
Lam, C.K., Yoo, T., Hiner, B., Liu, Z., and Grutzendler, J. (2010). Embolus
extravasation is an alternative mechanism for cerebral microvascular recana-
lization. Nature 465, 478–482.
Leao, A.A.P. (1944). Spreading depression of activity in the cerebral cortex.
J. Neurophysiol. 7, 359–390.
Logothetis, N.K., andWandell, B.A. (2004). Interpreting the BOLD signal. Annu.
Rev. Physiol. 66, 735–769.
Logothetis, N.K., Pauls, J., Augath, M., Trinath, T., and Oeltermann, A. (2001).
Neurophysiological investigation of the basis of the fMRI signal. Nature 412,
150–157.
Madisen, L., Mao, T., Koch, H., Zhuo, J.M., Berenyi, A., Fujisawa, S., Hsu,
Y.-W.A., Garcia, A.J., 3rd, Gu, X., Zanella, S., et al. (2012). A toolbox of
Cre-dependent optogenetic transgenic mice for light-induced activation and
silencing. Nat. Neurosci. 15, 793–802.
Motoike, T., Loughna, S., Perens, E., Roman, B.L., Liao, W., Chau, T.C.,
Richardson, C.D., Kawate, T., Kuno, J., Weinstein, B.M., et al. (2000).
Universal GFP reporter for the study of vascular development. Genesis 28,
75–81.
Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., and Luo, L. (2007). A global
double-fluorescent Cre reporter mouse. Genesis 45, 593–605.
Nakayama, A., Nakayama, M., Turner, C.J., Ho¨ing, S., Lepore, J.J., and
Adams, R.H. (2013). Ephrin-B2 controls PDGFRb internalization and signaling.
Genes Dev. 27, 2576–2589.
Nishiyama, A., Suzuki, R., and Zhu, X. (2014). NG2 cells (polydendrocytes) in
brain physiology and repair. Front. Neurosci. 8, 133.
Noguchi, H., and Gompper, G. (2005). Shape transitions of fluid vesicles and
red blood cells in capillary flows. Proc. Natl. Acad. Sci. USA 102, 14159–
14164.
Novak, A., Guo, C., Yang, W., Nagy, A., and Lobe, C.G. (2000). Z/EG, a double
reporter mouse line that expresses enhanced green fluorescent protein upon
Cre-mediated excision. Genesis 28, 147–155.
O’Farrell, F.M., and Attwell, D. (2014). A role for pericytes in coronary no-
reflow. Nat. Rev. Cardiol. 11, 427–432.
Ogawa, S., Lee, T.M., Kay, A.R., and Tank, D.W. (1990). Brain magnetic
resonance imaging with contrast dependent on blood oxygenation. Proc.
Natl. Acad. Sci. USA 87, 9868–9872.
Oku, H., Kodama, T., Sakagami, K., and Puro, D.G. (2001). Diabetes-induced
disruption of gap junction pathways within the retinal microvasculature. Invest.
Ophthalmol. Vis. Sci. 42, 1915–1920.
Pawlik, G., Rackl, A., and Bing, R.J. (1981). Quantitative capillary topography
and blood flow in the cerebral cortex of cats: an in vivo microscopic study.
Brain Res. 208, 35–58.
Peppiatt, C.M., Howarth, C., Mobbs, P., and Attwell, D. (2006). Bidirectional
control of CNS capillary diameter by pericytes. Nature 443, 700–704.
Puro, D.G. (2007). Physiology and pathobiology of the pericyte-containing
retinal microvasculature: new developments. Microcirculation 14, 1–10.
Raichle, M.E., and Mintun, M.A. (2006). Brain work and brain imaging. Annu.
Rev. Neurosci. 29, 449–476.
Rezkalla, S.H., and Kloner, R.A. (2002). No-reflow phenomenon. Circulation
105, 656–662.
Rouget, C. (1874). Note on the development of the contractile walls of blood
vessels. C. R. Acad. Sci. 79, 559–562.
Roy, C.S., and Sherrington, C.S. (1890). On the regulation of the blood-supply
of the brain. J. Physiol. 11, 85–158.17.110 Neuron 87, 95–110, July 1, 2015 ª2015 Elsevier Inc.Sagare, A.P., Bell, R.D., Zhao, Z., Ma, Q., Winkler, E.A., Ramanathan, A., and
Zlokovic, B.V. (2013). Pericyte loss influences Alzheimer-like neurodegenera-
tion in mice. Nat. Commun. 4, 2932.
Sakagami, K., Wu, D.M., and Puro, D.G. (1999). Physiology of rat retinal
pericytes: modulation of ion channel activity by serum-derived molecules.
J. Physiol. 521, 637–650.
Schain, A.J., Hill, R.A., and Grutzendler, J. (2014). Label-free in vivo imaging
of myelinated axons in health and disease with spectral confocal reflectance
microscopy. Nat. Med. 20, 443–449.
Shen, Z., Lu, Z., Chhatbar, P.Y., O’Herron, P., and Kara, P. (2012). An artery-
specific fluorescent dye for studying neurovascular coupling. Nat. Methods
9, 273–276.
Simard, M., Arcuino, G., Takano, T., Liu, Q.S., and Nedergaard, M. (2003).
Signaling at the gliovascular interface. J. Neurosci. 23, 9254–9262.
Skalak, R., and Branemark, P.I. (1969). Deformation of red blood cells in cap-
illaries. Science 164, 717–719.
Snippert, H.J., van der Flier, L.G., Sato, T., van Es, J.H., van den Born, M.,
Kroon-Veenboer, C., Barker, N., Klein, A.M., van Rheenen, J., Simons, B.D.,
and Clevers, H. (2010). Intestinal crypt homeostasis results from neutral
competition between symmetrically dividing Lgr5 stem cells. Cell 143,
134–144.
Somjen, G.G. (2001). Mechanisms of spreading depression and hypoxic
spreading depression-like depolarization. Physiol. Rev. 81, 1065–1096.
Uemura, A., Ogawa, M., Hirashima, M., Fujiwara, T., Koyama, S., Takagi, H.,
Honda, Y., Wiegand, S.J., Yancopoulos, G.D., and Nishikawa, S. (2002).
Recombinant angiopoietin-1 restores higher-order architecture of growing
blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110,
1619–1628.
Vanzetta, I., Hildesheim, R., and Grinvald, A. (2005). Compartment-resolved
imaging of activity-dependent dynamics of cortical blood volume and oxime-
try. J. Neurosci. 25, 2233–2244.
Vates, G.E., Takano, T., Zlokovic, B., and Nedergaard, M. (2010).
Pericyte constriction after stroke: the jury is still out. Nat. Med. 16, 959, author
reply, 960.
Wendling, O., Bornert, J.-M., Chambon, P., and Metzger, D. (2009). Efficient
temporally-controlled targeted mutagenesis in smooth muscle cells of the
adult mouse. Genesis 47, 14–18.
Winkler, E.A., Bell, R.D., and Zlokovic, B.V. (2011). Central nervous system
pericytes in health and disease. Nat. Neurosci. 14, 1398–1405.
Winkler, E.A., Sagare, A.P., and Zlokovic, B.V. (2014). The pericyte: a forgotten
cell type with important implications for Alzheimer’s disease? Brain Pathol. 24,
371–386.
Yemisci, M., Gursoy-Ozdemir, Y., Vural, A., Can, A., Topalkara, K., and
Dalkara, T. (2009). Pericyte contraction induced by oxidative-nitrative stress
impairs capillary reflow despite successful opening of an occluded cerebral
artery. Nat. Med. 15, 1031–1037.
Zariwala, H.A., Borghuis, B.G., Hoogland, T.M., Madisen, L., Tian, L., De
Zeeuw, C.I., Zeng, H., Looger, L.L., Svoboda, K., and Chen, T.-W. (2012).
A Cre-dependent GCaMP3 reporter mouse for neuronal imaging in vivo.
J. Neurosci. 32, 3131–3141.
Zhu, X., Bergles, D.E., and Nishiyama, A. (2008). NG2 cells generate both oli-
godendrocytes and gray matter astrocytes. Development 135, 145–157.
Zhu, X., Hill, R.A., Dietrich, D., Komitova, M., Suzuki, R., and Nishiyama, A.
(2011). Age-dependent fate and lineage restriction of single NG2 cells.
Development 138, 745–753.
